Oncology Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
12
NCT06546436
The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus
Phase: Early Phase 1
Role: Collaborator
Start: Aug 15, 2024
Completion: May 31, 2027
Loading map...